WPRIM Management System> DCMS> Chinese Journal of Nuclear Medicine and Molecular Imaging> 2020> 40

Volume: 40

1. Characteristics of primary mediastinal large B-cell lymphoma in 18F-FDG PET/CT imaging Page:1—5
2. Brain glucose metabolism network and connectivity in patients with somatoform disorders Page:6—10
3. Analysis of whole-body bone scintigraphy and SPECT/CT imaging in osteoid osteoma Page:11—15
4. Value of pathogenic diagnosis of 18F-FDG PET/CT imaging in non-traumatic unilateral vocal cord paralysis Page:16—20
5. Treatment response of differentiated thyroid carcinoma with negative preablative stimulated thyroglobulin and iodine-positive lymph node after the first radioablation and influence factors analysis Page:21—26
6. Experimental study of 18F-FDG PET/CT imaging and cardiac MRI in diagnosis of radiation-induced myocardial injury in Beagle dogs Page:27—31
7. The clinical value of combined 68Ga-SSA/18F-FDG PET/CT imaging in neuroendocrine neoplasms Page:47—51
8. Research progress of fluorescence imaging in neural localization Page:52—55
9. Experimental study of SPECT imaging with novel myocardial perfusion imaging tracer: 99Tcm-3SPboroxime Page:69—74
10. Comparison of 18F-Flurpiridaz and 13N-NH3·H2O PET/CT myocardial perfusion imaging in animal experiments Page:75—81
11. Experimental research of PET imaging with novel 18F-labeled myocardial perfusion imaging tracer: 18F-MyoZone Page:82—87
12. Value of non-contrast-enhanced MR angiography combined with captopril renal scintigraphy in the diagnosis of renovascular hypertension Page:88—92
13. Factors influencing the short-term efficacy of CT-guided 125I seeds implantation in the treatment of recurrent and metastatic tumors of head and neck Page:93—97
14. Protection management and procedures of nuclear medicine imaging during novel coronavirus (2019-nCov) infection epidemic period Page:105—107
15. Application of radionuclide myocardial perfusion imaging in patients with chronic kidney disease Page:108—112
16. Research progress of 6-18Ffluoro-L-dopa PET/CT imaging Page:113—117
17. Research progress of pretargeting strategies in antibody radiolabeling Page:118—121
18. Protection management and procedures of nuclear medicine imaging during novel coronavirus (2019-nCov) infection epidemic period Page:E001—E001
19. Expert consensus on the safety prevention and control of nuclear medicine diagnosis and treatment during the outbreak of COVID-19 (1st edition) Page:129—135
20. Characteristics of primary mediastinal large B-cell lymphoma in 18F-FDG PET/CT imaging Page:1—5
21. Brain glucose metabolism network and connectivity in patients with somatoform disorders Page:6—10
22. Analysis of whole-body bone scintigraphy and SPECT/CT imaging in osteoid osteoma Page:11—15
23. Value of pathogenic diagnosis of 18F-FDG PET/CT imaging in non-traumatic unilateral vocal cord paralysis Page:16—20
24. Treatment response of differentiated thyroid carcinoma with negative preablative stimulated thyroglobulin and iodine-positive lymph node after the first radioablation and influence factors analysis Page:21—26
25. Experimental study of 18F-FDG PET/CT imaging and cardiac MRI in diagnosis of radiation-induced myocardial injury in Beagle dogs Page:27—31
26. 18F-FDG PET/CT imaging in uterine atypical polypoid adenomyoma: a case report Page:37—38
27. 99Tcm-ECD SPECT/CT imaging in cerebral proliferative angiopathy: a case report Page:39—40
28. A case report of thyroid cancer combined with Langerhans cell histiocytosis Page:41—43
29. Differentiation of a retroperitoneal mass with somatostatin receptor scinfigraphy: a case report Page:44—46
30. The clinical value of combined 68Ga-SSA/18F-FDG PET/CT imaging in neuroendocrine neoplasms Page:47—51
31. Research progress of fluorescence imaging in neural localization Page:52—55
32. Novel myocardial perfusion imaging tracers promote the development of nuclear cardiology Page:65—68
33. Experimental study of SPECT imaging with novel myocardial perfusion imaging tracer: 99Tcm-3SPboroxime Page:69—74
34. Comparison of 18F-Flurpiridaz and 13N-NH3 · H2O PET/CT myocardial perfusion imaging in animal experiments Page:75—81
35. Experimental research of PET imaging with novel 18F-labeled myocardial perfusion imaging tracer: 18F-MyoZone Page:82—87
36. Value of non-contrast-enhanced MR angiography combined with captopril renal scintigraphy in the diagnosis of renovascular hypertension Page:88—92
37. Factors influencing the short-term efficacy of CT-guided 125I seeds implantation in the treatment of recurrent and metastatic tumors of head and neck Page:93—97
38. Risk factors and survival analysis of iodine tolerance in distant metastatic thyroid cancer Page:98—100
39. 18F-FDG PET/CT imaging in primary small cell neuroendocrine carcinoma of vagina: a case report Page:101—102
40. Differentiation of an atrium mass with 18F-FDG PET/CT imaging: a case report Page:103—104
41. Protection management and procedures of nuclear medicine imaging during novel coronavirus (2019-nCov) infection epidemic period Page:105—107
42. Application of radionuclide myocardial perfusion imaging in patients with chronic kidney disease Page:108—112
43. Research progress of 6-18F fluoro-L-dopa PET/CT imaging Page:113—117
44. Research progress of pretargeting strategies in antibody radiolabeling Page:118—121
45. Prognostic value of 18F-FDG PET/CT imaging and related factors for patients with classic Hodgkin lymphoma before or after autologous stem cell transplantation Page:147—152
46. Research progress of PET metabolic radiomics Page:183—186
47. Experimental study of 99Tc m-3PRGD 2 targeted receptor imaging on angiogenesis in rheumatoid arthritis Page:166—169
48. Room construction and installation of integrated PET/MR Page:187—190
49. Application of PET/CT imaging in chemotherapy-related cardiotoxicity Page:179—182
50. Predictive value of phase analysis of gated myocardial perfusion imaging for major adverse cardiac events in patients with coronary artery disease Page:136—141
51. Preoperative 11C-methionine PET imaging in glioma grading efficacy and its predictive value for IDH1 gene mutation status Page:153—158
52. Comparison of 13N-NH 3, 11C-MET and 18F-FDG PET/CT imaging in the diagnosis and evaluation of cerebral glioma Page:159—165
53. Clinical value of 125I seeds implantation in the treatment of primary liver cancer with portal vein tumor thrombus Page:142—146
54. Mid-long-term prognostic value of preoperative 18F-FDG PET/CT imaging on patients with resectable non-small cell lung cancer Page:219—223
55. Value of visual analysis and SUVR during 18F-AV45 PET/CT imaging in the diagnosis of mild cognitive impairment and Alzheimer′s disease Page:201—206
56. Application of 18F-AV45 PET imaging in subtle cognitive decline and mild cognitive impairment patients Page:196—200
57. Development of 177Lu-EB-RGD molecular probe and its imaging and therapy in the patient-derived xenografts of non-small cell lung cancer Page:231—237
58. Effects of different reconstruction algorithms on SUV of pulmonary nodules in 18F-FDG PET/CT Page:224—230
59. Application of PSMA ligands PET imaging in the diagnosis and treatment of non-prostate tumors Page:243—246
60. Study of statistical parametric mapping aided semi-quantitative analysis of 11C-PIB PET imaging acquired by hybrid PET/MR and its clinical application Page:207—212
61. Study on tau related disease pattern of Alzheimer′s disease based on 18F-APN-1607 PET imaging Page:213—218
62. Value of chemokines levels in predicting the progression of differentiated thyroid carcinoma Page:288—293
63. 18F-FDG PET/CT images quality and its impact factors in diabetic and non-diabetic patients with coronary artery disease Page:281—287
64. Enhancement of therapeutic efficacy by combination of integrin α vβ 3-targeted radiotherapy and anti-PD-L1 immunotherapy: a preclinical study Page:268—274
65. Vitro experiment of bone marrow mesenchymal stem cells mediated NIS gene and gold nanoparticles in the treatment of breast cancer Page:275—280
66. Visible light emitted quantum dots targeting EGFR in triple-negative breast cancer Page:260—267
67. Research development of nuclear imaging in ovarian cancer Page:311—315
68. Production and purification of solid target PET nuclide 89Zr and its antibody labeling Page:294—297
69. Serum thyroglobulin in evaluating the response to 131I treatment in patients with distant metastatic differentiated thyroid cancer Page:329—333
70. Correlation between 131I uptake and therapeutic efficacy in metastatic differentiated thyroid carcinoma: a retrospective multicenter study Page:334—338
71. Clinical value of 18F-FDG PET/CT in distinguishing benign from malignant cardiac tumors Page:351—356
72. Efficacy evaluation of percutaneous osteoplasty combined with 131I therapy and survival analysis in patients with bone metastasis from differentiated thyroid carcinoma Page:339—342
73. New progress in radioiodine therapy of differentiated thyroid cancer without distant metastases: the interpretation of Thyroid cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up Page:343—350
74. Evaluation of correlation between left ventricular mechanical contraction synchrony and left ventricular systolic function using a novel Cadmium-Zinc-Telluride SPECT Page:357—361
75. Biogenic gas vesicles labeled bone marrow mesenchymal stem cells: from synthesis to ultrasound imaging and tracking Page:362—367
76. Predictive value of stimulated thyroglobulin before the first 131I therapy for children and adolescents with differentiated thyroid carcinoma Page:324—328
77. Recent advances of aggregation-induced emission in tumor diagnosis and therapy Page:373—377
78. Analysis of variation patterns of focal physiological uptake in the tongue on 18F-FDG PET/CT imaging Page:415—420
79. Predictive value of diuretic renal scintigraphy after pyeloplasty in children with ureteropelvic junction obstruction Page:389—393
80. Efficacy of 18F-FDG PET/CT in the differential diagnosis of benign and malignant solitary pulmonary nodules Page:411—414
81. Renal depth measured by CT optimize the glomerular filtration rate using Gates method Page:399—405
82. Accuracy of glomerular filtration rate measured by 99Tc m-DTPA renal dynamic imaging (Gates method) in heart transplant recipients Page:406—410
83. Value of 99Tc m-DMSA renal SPECT/CT imaging in the diagnosis of upper urinary tract infection in adults Page:394—398
84. Prospects for the targeted treatment research of TSHR and IGF-1R in Graves disease and Graves ophthalmopathy Page:434—439
85. Advances of 18F-FDG PET/CT in the detection of brown adipose tissue Page:501—504
86. 18F-FDG PET/CT imaging in detection of panniculitis presenting as fever of unknown origin Page:459—463
87. Comparison of 68Ga-PSMA PET/CT and 18F-FDG PET/CT in the diagnosis of biochemical recurrence of prostate cancer Page:470—474
88. Application advances of simultaneous PET/MR imaging in cardiovascular disease Page:494—500
89. 18F-FDG PET/CT imaging in fever of unknown origin: data from a large single-center cohort Page:452—458
90. Clinical application of 18F-FDG PET/CT imaging in diagnosis of focal organizing pneumonia Page:464—469
91. Predictive value of 18F-FDG PET/CT for EGFR mutations in patients with lung adenocarcinoma Page:475—479
92. Preclinical and clinical translation research of 68Ga-labeled fibroblast activation protein inhibitor for PET imaging Page:480—485
93. Diagnostic value of 99Tc m-HSA SPECT/CT imaging for protein-losing enteropathy Page:523—527
94. Diagnostic value of 18F-FDG PET/CT for the appendiceal mucinous neoplasms Page:528—532
95. Value of FDG PET/CT in the differential diagnosis of benign and malignant hilar mediastinal lymph nodes in patients with non-small cell lung cancer Page:513—517
96. Diagnostic value of 18F-FDG PET/CT combined with integrated contrast-enhanced CT for hepatic epithelioid hemangioendothelioma Page:518—522
97. MicroPET and biodistribution of 68Ga-labeled human epidermal growth factor receptor 2 binding affibody imaging probe Page:538—544
98. Radiographic features of 18F-FDG PET/CT in the assessment of disease activity in adult-onset Still′s disease Page:533—537
99. Current status and progress of lung ventilation/perfusion imaging in the diagnosis of pulmonary embolism Page:563—566
100. Value of 18F-FDG PET/CT in the detection of the anthracycline induced cardiotoxicity in non-Hodgkin lymphoma Page:583—588
101. Comparison of response evaluation with EORTC criteria and PERCIST in breast cancer Page:625—628
102. Rapid determination of various fat-soluble vitamins in serum by isotope dilution ultra high performance liquid chromatography-tandem mass spectrometry Page:599—602
103. Application of 99Tc m-pyrophosphate in transthyretin cardiac amyloidosis Page:577—582
104. Value of thyroid radioactive iodine uptake on predicting the residual activity in patients with differentiated thyroid carcinoma after 131I treatment Page:595—598
105. Clinical practice of 177Lu-PSMA-RLT in the treatment of prostate cancer Page:621—624
106. Detection value of 18F-PSMA-1007 PET/CT in the recurrence of prostate cancer at low serum prostate specific antigen level Page:589—594
107. Experimental study of range verification of proton radiotherapy using off-line PET/CT Page:603—608
108. Progress of lanthanide-doping upconversion nanoparticles in multimodal and multiscale imaging Page:629—633
109. Dosimetry evaluation of three-dimensional-printing template guided radioactive seeds implantation assisted by navigation system in malignant tumors Page:641—646
110. Integrated CT renal depth correction for the GFR determination in the 99Tc m-DTPA renal dynamic imaging of patients with hydronephrosis Page:658—662
111. Analysis of quantitative parameters measured with PET/CT and relative risk factors in female patients with coronary microvascular diseases Page:652—657
112. Incremental value of chest thin layer CT over 99Tc m-3PRGD 2 SPECT/CT imaging in the diagnosis of solitary pulmonary space occupying Page:647—651
113. Impact of different post-processing correction techniques on the quantitative results of 99Tc m SPECT/CT Page:669—672
114. Application of 99Tc m-MDP SPECT/CT imaging in Langerhans cell histiocytosis in children Page:663—668
115. Application of α-emitters in precision medicine of malignant cancers Page:693—697
116. Research progress of PSMA PET tracers for prostate cancer Page:755—760
117. Quantitative evaluation of right ventricular myocardial blood flow using dynamic CZT SPECT imaging in patients with pulmonary arterial hypertension Page:705—709
118. Quantitative evaluation of the diffusion characteristics of calf muscles in type 2 diabetic mellitus patients by diffusion tensor imaging Page:716—720
119. Residual radioactivity and its influencing factors in patients with differentiated thyroid carcinoma after 131I therapy Page:721—725
120. Automatic preparation of 18F-Alfatide Ⅱ and its PET/CT imaging in prostate cancer Page:731—735
121. Investigation on knowledge of nurses in clinical ward on preparing patients for nuclear medicine examinations Page:726—730
122. Comparison of 68Ga-PSMA-617 and MRI in diagnosis and staging of primary prostate cancer Page:710—715

©2019 - Present World Health Organization Regional Office for the Western Pacific. All Rights Reserved.